I
The Most Trusted Name in Technology
II
A Century of Reinvention — The Official Narrative
III
The Shareholder Letter: Reading Between the Lines
IV
Wall Street's Consensus: Buy, Hold, and Trust
V
What the Analysts Said — and When They Said It
VI
The Pension Funds That Believed
VII
The Retail Investor: Last to Know, First to Lose
VIII
Revenue: The Headline That Hid the Decline
IX
Earnings Per Share: The Buyback Illusion
X
Free Cash Flow: Where the Money Actually Went
XI
Debt: Borrowing to Pay the Dividend
XII
Acquisitions: Buying Growth That Didn't Grow
XIII
Goodwill and Intangibles: The Balance Sheet's Hidden Weight
XIV
Margins Under Pressure: The Efficiency Story Unraveled
XV
The Stock Price vs. The Fundamentals: A Divergence in Plain Sight
XVI
The Board of Directors: Oversight Without Sight
XVII
The Auditors: Signing Off on Decline
XVIII
The Sell-Side Analysts: Conflicts and Consensus
XIX
The Rating Agencies: Too Slow, Too Late
XX
The Investment Advisors: Fiduciary Duty, Unexercised
XXI
The Regulators: What the SEC Could Have Required
XXII
The Financial Press: Repeating the Narrative
XXIII
The Investor's Loss: Quantified and Documented
XXIV
IBM Is Not an Anomaly — It Is the Template
XXV
The "What Must Happen" Test: Applied to IBM
XXVI
The Standard of Care: From Narrative to Mathematics
XXVII
What Every Advisor Needs to Know
XXVIII
Regulatory Recommendations: Closing the Compliance Gap
XXIX
The Fiduciary Mandate
XXX
Conclusion: The Numbers Were Always There
A
Complete ERS Analytical Output for IBM: Three Critical Dates
B
IBM Financial Summary: 25-Year Trend Data
C
Valuation Risk Case Studies with Rating Correspondence
D
Methodology: The ERS Risk Rating Framework